ARCHIVES

Targeting One Specific Protein Can Double PFS; Triple Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

January 8, 1993

Sen. Dole Raps HEW Over Delays On Patent Requests

August 11, 1978

Heart Failure Rare Among Leukemia Patients On Imatinib

September 28, 2007

HHS News: Shalala Appoints Group On Genetic Testing

June 25, 1999

Cervarix Vaccine Approved To Prevent Cervical Cancer

October 30, 2009

Also in this 12-page issue: NCI’s Lance Liotta and FDA’s Emanuel Petricoin to move to George Mason University.

March 11, 2005